Abstract
Background:
Mycobacteriophages targeting Mycobacterium tuberculosis, show promise as adjuncts for treating drug resistant tuberculosis. While mycobacteriophages encode mycobacterial cell wall degrading enzymes, their interaction with the host during infection is poorly understood. In other bacteria, lytic transglycosylases, homologous to mycobacterial resuscitation-promoting factor, RpfB, have been implicated in facilitating infection. Given the multiplicity of Rpf homologues in mycobacteria, we explored their individual and combined roles in mycobacteriophage infection.
Materials and Methods:
Soil-derived mycobacteriophages, MontyDev and Bora were isolated and tested on Mycobacterium smegmatis strains carrying various rpf gene deletions.
Results:
Complete loss of Rpf proteins led to ∼75% reduction in plaque formation, which was reversed by complementation with specific Rpf proteins. RfpC, RpfD, and RpfE were dispensable for bacteriophage infection, while RpfA and RpfB showed differential requirements, with MontyDev requiring both and Bora dependent on RpfB.
Conclusion:
Our data suggest potential interactions between mycobacteriophage proteins and host cell wall transglycosylases during infection.
Introduction
The emergence of drug-resistant tuberculosis (TB) threatens to undermine global TB control.1,2 Drug resistant strains require protracted treatment with expensive drugs that are associated with poor treatment outcomes and adverse side-effects. 3 Hence, alternative therapeutics such as bacteriophages have been explored and gained much attention for the treatment of several recalcitrant antimicrobial resistant infections.4–7 Bacteriophages are also inherently noninfectious to humans and, therefore, are attractive therapeutics for drug-resistant infections.8,9
Bacteriophages are classified as virulent or temperate. While temperate bacteriophages can enter a lysogenic lifestyle in which they integrate into the genome of the host and replicate via cell division, virulent bacteriophages exclusively induce lysis. 10 Although some bacteriophages have a broad host range, many display high specificity for recognition of distinct receptors on the host bacterial cell wall for infection. 11 For bacteriophages infecting mycobacterial species, the cell wall presents a significant barrier to entry due to its complex structure comprised of mycolic acids, arabinogalactan and peptidoglycan (PG) layers. 12 Mycobacteriophages require enzymes that break the cell wall to enable DNA entry, replication and subsequent lysis. Consequently, the genomes of most mycobacteriophages encode such enzymes, including Lysin A and Lysin B that hydrolyse the PG and degrades the ester bond anchoring mycolic acids to arabinogalactan respectively as well as Holins that regulate the timing of lysis.13–16 While there is emerging evidence pointing to mechanisms of bacteriophage systems, the contribution of bacterial host factors in response to infection is sparse. Recently, a lytic bacteriophage which colonizes a bacterium Schaalia odontolytica that resides in the oral cavity, was shown to exploit the host-encoded lytic transglycosylase (LT), facilitating bacteriophage binding and infection. This LT showed a high level of structural homology to the resuscitation promoting factor, RpfB, of Mycobacterium tuberculosis. 17 In mycobacteria the lysozyme-like transglycosylase domain in RpfB is predicted to cleave the glycan backbone of PG to allow for the insertion of new PG units during bacterial replication. 18 Mycobacteria encode a multiplicity of LTs, in some instances up to five (designated as RpfA-RpfE in M. tuberculosis) that have demonstrated roles in the hydrolysis of bacterial PG.19–21 Herein, we aimed to assess whether changes in the PG due to a lack of Rpf activity influenced susceptibility to two newly identified mycobacteriophages.
Materials and Methods
Bacterial strains and culture conditions
All bacterial strains and plasmids used in this study are listed in Table 1. Escherichia coli DH5α was grown in LB broth or on LB agar. Mycobacterium smegmatis strains were grown in 7H9 (Difco) Middlebrook supplemented with 0.5% glycerol, 0.2% glucose, 0.085% NaCl and 0.05% Tween-80 or tyloxapol or on 7H10 (Difco) agar medium supplemented with 0.5% glycerol, 0.2% glucose and 0.085% NaCl. Hygromycin was added at 200 μg/mL for E. coli and 50 μg/mL for M. smegmatis as needed.
Plasmids and Strains Used in This Study
ApR, ampicillin-resistant; HygR, hygromycin-resistant; KmR, kanamycin-resistant; Rpf, resuscitation-promoting factor; WT, wildtype.
Drug susceptibility and permeability testing
M. smegmatis mc2155 strain (wildtype, WT), the rpf deletion mutant (Δrpf) and the various rpf complemented derivatives (Table 1) were grown to exponential phase. Cultures were adjusted to optical density (OD)600 nm = 0.4, serially diluted (10−1 to 10−5), and appropriate dilutions plated on 7H10 agar to assess colony forming units (CFU/mL). In addition, 10 μL of each dilution was aliquoted onto 7H10 media supplemented with 0.004% sodium dodecyl sulfate (SDS) or 3 μg/mL vancomycin and un-supplemented plates served as controls. The plates were incubated at 37°C for 4 days before scoring for growth. The experiment was performed in triplicate.
Growth kinetics of the M. smegmatis wild type, rpf deletion mutant and complemented strains
Triplicate cultures of the WT, Δrpf and the various rpf complemented derivatives (Table 1) were inoculated at an OD600 nm of 0.05 in 7H9 media with tyloxapol using overnight precultures grown in the same media. Cultures were incubated with shaking at 37°C and OD600 nm was first measured 16 h, then at 3- and 16-h intervals over a 48-h period. The OD600 nm measurements for the three biological replicates were averaged and plotted against time.
Preparation of M. smegmatis for bacteriophage infection
A single colony of each M. smegmatis strain was grown overnight in 5 mL of 7H9 medium at 37°C with shaking at 100 rpm. Pre-cultures were diluted 1:100 into 50 mL 7H9 and grown to mid log phase (OD600 nm = 0.8) or late log phase (OD600 nm = 2). Cultures were harvested by centrifugation at 4 500 × g, washed twice with 30 mL of mycobacteriophage (MP) buffer (10 mM Tris pH 7.5, 10 mM MgSO4, 1 mM CaCl2, and 68.5 mM NaCl), and resuspended in the appropriate volume of MP buffer to an OD600 nm of 2.
Purification and amplification of mycobacteriophages
To isolate mycobacteriophages, 2 mL of soil samples were resuspended in 10 mL of MP buffer, shaken (200 rpm) for 2 h at 37°C and the supernatant filtered using a Membrane filtration (MF)-Millipore® Membrane 0.22 μm filter. Ten 50 μL aliquots were mixed with 450 μL of the WT strain (OD600 nm = 2) at room temperature for 30–60 min. Following addition of 4.5 mL of Mycobacteriophage top agar (MPTA), mixtures were overlaid on 7H10 plates and incubated at 37°C for 2–3 days. MPTA contains 7H9 (Difco) Middlebrook liquid medium, supplemented with 1.14% LB-agar, 0.2% glycerol, 0.2% glucose, 0.085% NaCl, and 0.1% CaCl2. Single plaques were picked and resuspended in 1 mL of MP buffer. The suspension was filtered, serially diluted (10−1–10−10) and 450 μL of WT cells were added to 50 μL of each dilution of the mycobacteriophage (multiplicity of infection [MOI] 1:10, mycobacteriophage to bacteria) to ascertain the dilution yielding confluent (‘lacey’) plaques. High titer lysate was prepared by overlaying several ‘lacey’ plates with 3 mL of MP buffer each and incubating the plates for 4–6 h at room temperature with intermittent manual agitation. The pooled mycobacteriophage suspensions were collected, filter sterilized and the plaque-forming units (PFU)/mL assessed as described above. The mycobacteriophage lysates were stored at 4°C.
Mycobacteriophage Infection of M. smegmatis Wild Type, Rpf Deletion Mutant, and Complemented Strains
High titer lysates of both mycobacteriophages were serially diluted (100–10−10) to confirm PFU/mL. Infections were performed at a MOI of 1:10 (mycobacteriophage:bacteria). Following 15–60 min of adsorption at room temperature, mixtures were combined with MPTA and overlaid on 7H10 plates. Plates were incubated at 37°C for 2–3 days and PFUs/mL were calculated and presented as a percentage relative to the WT strain.
Adsorption assays
A single colony of the WT, Δrpf, and Δrpf::rpfAB, was inoculated in 10 mL of 7H9 medium and incubated overnight at 37°C with shaking at 100 rpm. Pre-cultures were diluted 1:100 in 100 mL and grown overnight to mid log phase (OD 600 nm = 0.8) or late log phase (OD 600 nm = 2). Cells were harvested by centrifugation at 4 500 × g, washed twice with 40 mL of MP buffer and the pellets resuspended in the appropriate volume of MP to OD600 nm of 2. For infection, 2.7 mL aliquot of each strain was mixed with 300 μL of high titer mycobacteriophage lysate (∼ 109 PFU/mL) at an MOI of 1:10 and incubated at 37°C with gentle shaking at 30 rpm. At time points 0-, 15-, 30-, 60-, 90-, and 120-min post infection, 300 μL of the mycobacteriophage cell suspension was collected, vortexed for 5 s where appropriate and centrifuged at 20,000 × g for 30 s. Supernatant containing un-adsorbed bacteriophages, was carefully aspirated, diluted serially (100–10−10), and 50 μL of each dilution was used to infect 450 μL WT cells (OD600 = 2). After 15 min of incubation at room temperature, MPTA overlays were poured on 7H10 plates. Plates were incubated at 37°C for 2–3 days and the percentage PFU/mL relative to WT was calculated with data representing the average of three biological repeats.
Negative staining transmission electron microscopy
Transmission electron microscopy was performed at the Electron Microscope Unit, University of Cape Town, South Africa. Briefly, carbon-coated copper grids (Agar Scientific, UK) were made hydrophilic using a EMS100 Glow Discharge Unit (Electron Microscopy Sciences, USA). Samples were applied to the grids and negatively stained with 2% uranyl acetate (SPI Supplies, USA). Imaging was performed on a FEI T20 transmission electron microscope (Thermo Fisher [formerly FEI], Eindhoven, Netherlands) at 200 kV and images were collected using a Gatan US 1000 CCD camera (Ametek Inc., USA).
Extraction, whole genome sequencing, and annotation of mycobacteriophage DNA
Details are provided in the Supplementary Data.
Construction of M. smegmatis strains expressing single M. tuberculosis rpfA or rpfB homologues
In a previous study, we generated the pMV-RPFAB integrating plasmid with rpfA and rpfB genes from M. tuberculosis. 19 This vector was further manipulated to generate pMV-RPFAΔint and pMV-RPFBΔint, as described in the Supplementary Data.
Data analysis
Graphs and figures were generated using Microsoft PowerPoint, Excel, GraphPad Prism (version 10.2.3) or Biorender.com software. GraphPad Prism (version 10.2.3) was used for all statistical analysis and data comparisons.
Results
Isolation, purification, and characterization of lytic mycobacteriophages
Two mycobacteriophages were isolated from damp soil collected in Johannesburg, South Africa: MontyDev from under a lavender bush (Benoni, GPS co-ordinates −26.1777°, 28.2838°) and Bora from a flowerbed (Braamfontein, GPS co-ordinates −26.1947°, 28.0323°). Both mycobacteriophages formed circular, turbid zones of clearance, on a lawn of WT M. smegmatis cells, with MontyDev ∼1–2 mm (Fig. 1A) and Bora in ∼1 mm in size (Fig. 1B). Transmission electron microscopy revealed that both mycobacteriophages are siphoviral with long, non-contractile tails (Fig. 1C and D). MontyDev has a ∼71 nm diameter icosahedral capsid and a ∼284 nm long tail, whereas Bora has a prolate capsid, measuring ∼163 nm long and ∼40 nm wide, with a ∼247 nm long tail.

Characterization of mycobacteriophage plaque morphology and virion morphotype.
Genomic analysis of mycobacteriophages MontyDev and Bora
Whole genome sequencing confirmed that both mycobacteriophages are siphoviral with MontyDev in cluster R and Bora in cluster O. No integrase genes were detected in both the genomes, suggesting they are virulent mycobacteriophages. Neither mycobacteriophage genome contain tRNA or tmRNA reading frames. Predicted gene functions include structural, packaging, DNA replication, lytic, packaging and assembly, and hypothetical proteins (Supplementary Table S1). MontyDev has 71,250 bp, a G + C content of 56.0%, 101 predicted open reading frames, of which 70 (69.3%) are hypothetical proteins. All open reading frames except one (MONTYDEV_42) are transcribed from the forward, positive strand (Fig. 2A, Supplementary Table S1). The genome of Bora has 71,494 bp, a G + C content of 65.3%, and 124 predicted open reading frames, of which 82 (66.1%) are hypothetical proteins. Of these 124 genes, 54 are transcribed from the forward and 70 from the reverse strand (Fig. 2B, Supplementary Table S1). Both MontyDev and Bora contain the endolysins Lysin A and Lysin B, while the Holin protein is present only in Bora (Fig. 2A and B, Supplementary Table S1). Sequencing and annotation information for both mycobacteriophages is available at the Sequence Read Archive (BioProject numbers PRJNA1108268 and PRJNA1108264, respectively), the Actinobacteriophage Database (https://phagesdb.org) under https://phagesdb.org/phages/MontyDev/ and https://phagesdb.org/phages/Bora/, and Genbank (Accessions numbers PP763599 and PP763600, respectively).

Graphic representation of the genomes of mycobacteriophages MontyDev and Bora. The images were produced based on output from the Phamerator website (https://phamerator.org/phages). Nomenclature follows the guidelines as stipulated at the SEA-PHAGES Program (https://phagesdb.org/media/workflow/protocols/pdfs/Function_Assignments_best.pdf).

(Continued).
Susceptibility of M. smegmatis strains with and without rpfs to MontyDev and Bora
We previously generated M. smegmatis strains in which a mutant (Δrpf) devoid of all its chromosomal rpf genes (rpfA, rpfB, rpfE and rpfE2) was complemented with combinations of the five M. tuberculosis rpf genes with their cognate promoters. 22 In our prior work, we generated a set of plasmids containing different combinations of the rpf genes from M. tuberculosis. The homology between M. tuberculosis and M. smegmatis rpfA and rpfB alleles at the protein level is high (see Supplementary Fig. S1). The rpfA gene from the two organisms share a 44.7% identity (entire length of 515 amino acids [aa]) with a 90.7% similarity in transglycosylase domain PF06737 (68/75 aa), whilst the rpfB alleles share a 74.4% identity (entire length 375 aa), with 90.7% similarity in transglycosylase domain PF06737 (68/75 aa). AlphaFold predictions for RpfA generate space filling models which all contain the conserved PF06737 domain (blue, high confidence in ribbon model; green block, low expected error) (Supplementary Fig. S2). RpfA and RpfB show highly conserved predictions for the entire length of the protein, while RpfC, RpfD, and RpfE contain the conserved PF06737 domain flanked by regions of lower confidence (Supplementary Fig. S2).
We first infected the various strains with MontyDev at a MOI of 1:10 to assess the role of rpf genes for mycobacteriophage infection. The Δrpf mutant and the Δrpf complemented with RpfCDE Mtb (Δrpf::RpfCDE Mtb ) yielded lower PFUs/mL compared to WT (Fig. 3A). However, combinatorial addition of rpfABMtb to Δrpf (Δrpf::RpfAB Mtb ) showed a significant recovery in PFUs/mL, albeit still less than WT. The addition of rpfABMtb to Δrpf::RpfCDE Mtb to generate a strain containing all the M. tuberculosis rpfs (Δrpf::RpfABCDE Mtb ) resulted in similar plaques levels as Δrpf::RpfAB Mtb suggesting that RpfA and RpfB together contribute to mycobacteriophage infection (Fig. 3A).

Infection of Mycobacterium smegmatis strains with lytic phages MontyDev and Bora. The mycobacteriophages were incubated with the respective bacterial cells at a MOI of 1:10 (1 mycobacteriophage:10 bacteria) and allowed to adsorb for at least 15 min. PFU were assessed by mixing the bacteriophage and cell suspension with top agar and overlaid on 7H10 plates.
To evaluate the individual role of RpfA and RpfB in bacteriophage infection, each gene from M. tuberculosis was cloned into integrative plasmids and electroporated into Δrpf to generate strains Δrpf::RpfA Mtb and Δrpf::RpfB Mtb , respectively (Table 1). Quantitative polymerase chain reaction (PCR) confirmed the expression of the introduced genes in Δrpf (Supplementary Fig. S3). Only expression of rpfA and rpfB was assessed in WT since M. tuberculosis does not have the equivalent of the M. smegmatis rpfE and rpfE2 homologues. In M. smegmatis, expression of the rpfAMsm transcript was ∼10-fold higher than the rpfBMsm transcript (Supplementary Fig. S3). Complemented Δrpf strains expressed all M. tuberculosis rpf genes, albeit at varying degrees. We expected some differences in rpf gene expression in the recombinant M. smegmatis strains, as native M. tuberculosis promoters were used. Indeed, the rpfCMtb transcript was most abundant, while expression of the remaining M. tuberculosis genes was more comparable in each of the complemented strains, and to the M. smegmatis rpfA and rpfB genes (Supplementary Fig. S3). Despite these variations, our prior work using these heterologous complemented strains restored biofilm forming defects in M. smegmatis rpf deficient mutants. 19 Based on these data we tested the effect of rpf gene deletion on drug susceptibility and permeability. The Δrpf mutant showed a 2–3 log reduction in growth in the presence of 3 μg/mL vancomycin and 0.004% SDS which was rescued by rpfA and rpfB individually and in combination to WT levels (Supplementary Fig. S4). Comparison of growth kinetics showed no significant viability defect between the Δrpf and the three complemented strains Δrpf::RpfABMtb, Δrpf::RpfA Mtb and Δrpf::RpfB Mtb . The WT strain displayed a small but significant difference in growth rate between 10 and 30 h; however, this difference was subsequently abrogated. The WT strain showed reduced growth in stationary phase; however, this was minor and likely due to clumping that routinely occurs in mycobacterial cultures at this stage of growth (Supplementary Fig. S5).
Both Δrpf::RpfA Mtb and Δrpf:RpfB Mtb , when infected with cluster R mycobacteriophage MontyDev, showed increased plaque formation, compared to Δrpf (∼25% vs. ∼10%). However, Δrpf::RpfAB Mtb showed more than double the plaque-forming ability compared with the single gene complements, indicating synergy between RpfA and RpfB (Fig. 3B). To assess if this synergy was broadly applicable in mycobacteriophages, we tested the susceptibility of the cluster O mycobacteriophage, Bora (Fig. 3C). Infection of Δrpf::RpfAB Mtb again yielded similar increased plaque-forming ability as observed with MontyDev, i.e., partial complementation of Δrpf (∼75%). However, the plaque-forming ability of Bora in Δrpf::RpfB Mtb was comparable to that of Δrpf::RpfAB Mtb (∼65% vs ∼75%), while the Δrpf::RpfA Mtb resulted in lower but similar levels of PFU/mL for both MontyDev and Bora (∼25%) (Fig. 3C).
To determine if the reduction in PFU/mL observed for the Δrpf mutant was due to an adsorption defect, we adapted an assay that monitors adsorption of phage over a period of 120 min, 24 in mid and late log phase (OD600 nm = 0.8 and OD600 nm = 2.0, respectively), shown in Figure 4A. While MontyDev showed no adsorption differences between strains grown to late log phase, Bora exhibited some variation in adsorption under the same conditions. However, none of these differences reached statistical significance (Fig. 4B and C). To account for possible difference in cell wall structure for late log phase cells, we also tested adsorption at a lower optical density (OD600 nm = 0.8, corresponding to mid log phase) and included a vortexing step to remove unbound bacteriophage. Under these conditions MontyDev showed a marginal reduction in adsorption with the Δrpf mutant after 60 min compared with WT, an effect that was reversed with genetic complementation however, these differences were not statistically significant (Fig. 4D). Bora displaced comparable levels of adsorption with the wild type (Fig. 4E).

Comparison of adsorption of mycobacteriophages to Mycobacterium smegmatis cells in mid and late log growth phase.
Discussion
Mycobacteriophages infecting M. tuberculosis and nontuberculous mycobacteria are gaining interest as novel adjunctive treatments for drug resistant infections.25–27 Understanding mycobacteriophages and their interactions with specific host factors is key for potential clinical applications. 11 Despite bacteriophage genomes being relatively small (∼15 to ∼500 kbp), many bacteriophage genes are annotated as hypothetical proteins, based on bioinformatic and computational tools to other bacteriophages. Assigning specific biological function to these proteins could advance our understanding of phage–host interactions and resistance mechanisms.
Mycobacteria have multiple rpf genes, with four representatives in M. smegmatis (rpfA, rpfB, rpfE, and rpfE2) and five in M. tuberculosis (rpfA-E). 28 We exploited a M. smegmatis mutant strains lacking all rpf genes and various complemented derivatives thereof expressing various combinations of M. tuberculosis rpf genes, to investigate how host encoded rpf genes affect susceptibility to MontyDev and Bora. Infection of Δrpf with these mycobacteriophages resulted in a significant reduction in PFU/mL compared with WT, indicating decreased vulnerability to infection in the absence of rpf genes. Strains complemented with rpfA and rpfB together (but not rpfC, rpfD and rpfE), showed partial restoration of susceptibility to MontyDev (cluster R). To further delineate the role of rpfA and rpfB, complemented derivatives containing either rpfA or rpfB separately also showed increased susceptibility to MontyDev compared to Δrpf, but not to the level observed with combined complementation with rpfA and rpfB. For Bora (cluster O), a complemented derivative containing rpfB alone, increased plaque formation compared to the strain containing rpfA only, though not to the level of WT. Our data suggest that MontyDev requires both rpfA and rpfB, while Bora is more dependent on rpfB for optimal mycobacteriophage infection. Our previous work demonstrated that deletion of all four Rpf homologues in M. smegmatis reduced muropeptides production and altered PG cross-linking, effects which were reversed by simultaneous complementation with rpfAMtb and rpfBMtb. 19 In this context, the growth defect of the rpf deficient mutant strain in the presence of vancomycin and SDS was fully rescued with rpfA and rpfB, individually and in combination to WT levels. Despite these changes, the rpf deletion mutant maintained viability, exhibiting growth kinetics comparable with both WT and complemented strains.
The reduction in PFU observed with the ΔrpfAB double mutant could be owed to receptor masking, preventing mycobacteriophage adhesion due to structural changes in the PG or disruption of protein interactions between mycobacteriophages and host. To test this, we performed adsorption assays but observed no differences in bacteriophage binding between strains for either mycobacteriophage during mid and late log growth phases of the cells.
A bioinformatic analysis of Lysin A proteins from 224 sequenced mycobacteriophages revealed that these enzymes are widespread, diverse and extensively modular, featuring functional domains such as N-terminal peptidases, amidases, muramidases or transglycosylases, and C-terminal putative cell wall binding domains.29,30 Lysin B proteins, cleave the ester bonds between arabinogalactan and mycolic acids in the mycobacterial cell wall, but are not present in all mycobacteriophages.29,30 Many mycobacteriophage genomes also encode Holin proteins that span the cell membrane and allow Lysins to pass into the extracellular milieu. 30 Co-ordinated timing achieved by disruption of the proton motive force across the cell membrane releases the Lysins to start hydrolysis of the PG layer and disrupt the mycobacterial outer membrane simultaneously, leading to cell death and bacteriophage release.31,32
In light of the broad repertoire of enzymes involved in bacteriophage DNA entry and lysis, we examined how mycobacteriophages MontyDev and Bora infect M. smegmatis mutants lacking LT activity. Both mycobacteriophages are siphoviral but differ in their arsenal of genes encoding PG lytic activity. MontyDev has PG-degrading activity in Lysin A (MONTYDEV_35), in two distinct domain, i.e., a N-terminal l-alanyl-d-glutamate peptidase domain (M15_C family) and a C-terminal lysozyme-like domain (GH_19 superfamily). The PG degradation of Bora potentially involves two proteins: Lysin A (BORA_64), with a predicted N-acetylmuramoyl-l-alanine amidase domain (Ami_2 family), and a minor tail protein with a D-ala-D-ala carboxypeptidase domain (S11 family, BORA_57). The genomes of both mycobacteriophages encode a Lysin B, but only Bora contains the Holin gene, operonic with Lysin A and Lysin B, which is typical for cluster O bacteriophages. 14 Generally, Lysin B is positioned either immediately downstream of Lysin A, or it is separated by a maximum of four genes, often encoding putative Holin proteins in some bacteriophages.33,34 Although MontyDev displayed this genetic arrangement, the three hypothetical proteins separating Lysin A and Lysin B do not contain any predicted genetic domains typical of Holins or other lysis proteins, suggesting that it accesses the periplasmic space by yet an unidentified mechanism(s).
PG-hydrolysing motifs corresponding to peptidase and transglycosylase activities located within TMPs of bacteriophages has also been shown to be a common strategy employed by bacteriophages infecting Gram-positive bacterial hosts.35,36 Our analysis revealed that the TMP of MontyDev contains a lysozyme-like domain however, the role of this protein in this mycobacteriophage is unclear. Lysin B from related bacteriophages have shown broad activity against various mycobacterial species37–40 and, when combined with anti-TB drugs, can target drug-resistant M. tuberculosis in macrophages without harming host cells. 41 Conversely, the bacteriophage LC001 exploited a host LT, similar to the mycobacterial RpfB protein to enhance receptor binding and infection in the bacterium Schaalia odontolytica. 17 M. tuberculosis PG remodeling enzymes have also been shown to interact transiently with other proteins such as RpfB and the d,l-endopeptidase, Rpf interacting protein A (RipA) to remodel PG. 21 Similarly, mycobacteriophage proteins may exploit host Rpf proteins to facilitate cell lysis.
Conclusion
In summary, our data suggest that mycobacteriophages from different clusters have differential requirements for Rpf proteins in mycobacteria, while our research suggests that Rpf activity is required for mycobacteriophage infection, the exact molecular mechanism(s) by which mycobacteriophage enzymes interact with host encoded Rpf proteins to cleave PG remains to be fully elucidated.
Footnotes
Acknowledgment
The authors thank Deborah Jacobs-Sera, Daniel A. Russell, and Graham F. Hatfull (Department of Biological Sciences, University of Pittsburgh, Pittsburgh, PA, USA) for their technical support related to the raw sequence analysis and genome annotations. The authors thank Mohamed Jaffer (Electron Microscope Unit at the University of Cape Town, Cape Town, South Africa) for assistance with microscopy and Inqaba Biotec, a commercial next generation sequencing service provider, for assistance with whole-genome sequencing. The authors also thank Danishka Moodley, Dhanishta Patel, Serene Keenan, Yuveshni Chetty and Astika Sewcharran for their technical support.
Authors’ Contributions
Conceptualization: B.D.K., B.G.G., C.S.E., and E.E.M. Data curation; C.M., K.G., and N.S. Formal analysis: C.M., C.S.E., E.E.M., and B.G.G. Funding acquisition: B.D.K. Investigation: C.M., K.G., N.S., and B.G.G. Methodology and validation: B.G.G., C.S.E., C.M., E.E.M., K.G., and N.S. Project administration: B.G.G., C.S.E., and E.E.M. Resources: B.D.K. Software: Not Applicable. Supervision: B.G.G., B.D.K., C.S.E., and E.E.M. Visualization: Not Applicable; Writing—original draft: B.G.G. Writing—review and editing: B.G.G., B.D.K., C.S.E., C.M., E.E.M., K.G., and N.S.
Author Disclosure Statement
No competing financial interests exist.
Funding Information
This study was supported with funds from the South African Department of Science and Innovation and the National Research Foundation (DCOE015).
